Effects of an oncology Exercise therapy with equipment on the quality of life of oncological patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023912

Enrollment

200

Registered

2020-12-23

Start date

2021-04-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Questionnaire and functionality survey before and after completion of the intervention (prospective longitudinal study).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: men and women = 18 years of age, - current or within the last 24 months a final-digit coded diagnosis according to ICD: C00* – C97* Malignant neoplasms - are proficient in the German language in words and in writing, - the patient must be physically and psychosocially able to participate in the care model (certificate of safety by the specialist)

Exclusion criteria

Exclusion criteria: Absolute contraindications: acute infectious diseases, fresh wounds, fresh myocardial infarction (< 4 weeks), unstable angina pectoris, clinically relevant heart failure (NYHA III and IV), higher-grade valve vitias, uncontrolled cardiac arrhythmia, chronic obstructive pulmonary disease, haemoglobulin < 4. 8 mmol/ l, platelets < 20 Gpt/ l, fresh thrombosis/ pulmonary embolism, new severe pain symptoms

Design outcomes

Primary

Measure	Time frame
Effects of oncological exercise therapy on patients' global quality of life (EORTC-QLQ-30)	—

Secondary

Measure	Time frame
Patient reported outcomes (PROs) - Fatigue (MFI-20) - PNP (FACT/GOG-NTX-13 (version 4); PainDetect) - Physical Activity Level (GSLTPAQ) - Performance diagnostics - Body composition (BIA) - Balance (Timed up and go test, > 75 years) - Force abilities (maximum force on equipment) - cardiopulmonary performance (maximum and relative performance on the bicycle ergometer) • Other - Dropout rate and reasons for premature termination of training - Period 1-24 training session (stimulus density) - Grounds for exclusion - Adverse Events	—

Measure

Time frame

Patient reported outcomes (PROs) - Fatigue (MFI-20) - PNP (FACT/GOG-NTX-13 (version 4); PainDetect) - Physical Activity Level (GSLTPAQ) - Performance diagnostics - Body composition (BIA) - Balance (Timed up and go test, > 75 years) - Force abilities (maximum force on equipment) - cardiopulmonary performance (maximum and relative performance on the bicycle ergometer) • Other - Dropout rate and reasons for premature termination of training - Period 1-24 training session (stimulus density) - Grounds for exclusion - Adverse Events

—

Countries

Germany

Contacts

Public ContactJulia Grün

Universitätsmedizin Rostock Zentrum für Innere MedizinKlinik III (Hämatologie, Onkologie, Palliativmedizin)

julia.gruen@med.uni-rostock.de0381 494 7326

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026